These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14506111)

  • 1. Diagnosis of nonalcoholic fatty liver disease.
    Yanai H; Morimoto M
    JAMA; 2003 Sep; 290(12):1577; author reply 1578. PubMed ID: 14506111
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-invasive tests for liver fibrosis: encouraging or discouraging results?
    Burroughs AK; Cholongitas E
    J Hepatol; 2007 May; 46(5):751-5. PubMed ID: 17383047
    [No Abstract]   [Full Text] [Related]  

  • 3. Will non-invasive markers replace liver biopsy for diagnosing and staging fibrosis in non-alcoholic steatohepatitis?
    Hashimoto E; Farrell GC
    J Gastroenterol Hepatol; 2009 Apr; 24(4):501-3. PubMed ID: 19368628
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonalcoholic steatohepatitis.
    Williams CN
    Can J Gastroenterol; 1999 Oct; 13(8):639-40. PubMed ID: 10545649
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
    Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study.
    de Lédinghen V; Ratziu V; Causse X; Le Bail B; Capron D; Renou C; Pilette C; Oules V; Gelsi E; Oberti F; Vallet-Pichard A; Le Provost N; Cadranel JF; ;
    J Hepatol; 2006 Oct; 45(4):592-9. PubMed ID: 16837098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease.
    Adams LA; Angulo P
    Clin Liver Dis; 2007 Feb; 11(1):25-35, viii. PubMed ID: 17544970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric initiatives within the Nonalcoholic Steatohepatitis-Clinical Research Network (NASH CNR).
    Lavine JE; Schwimmer JB;
    J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):220-1. PubMed ID: 12971361
    [No Abstract]   [Full Text] [Related]  

  • 9. Hematocrit is associated with fibrosis in patients with nonalcoholic steatohepatitis.
    Li Y; Liu L; Wang B; Wang J; Chen D
    Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):332-8. PubMed ID: 24172912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply: To PMID 21953442.
    Kowdley KV; Nelson J
    Hepatology; 2013 May; 57(5):2095. PubMed ID: 22987775
    [No Abstract]   [Full Text] [Related]  

  • 11. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease.
    Angulo P; Alba LM; Petrovic LM; Adams LA; Lindor KD; Jensen MD
    J Hepatol; 2004 Dec; 41(6):943-9. PubMed ID: 15582127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease.
    Nobili V; Alisi A; Torre G; De Vito R; Pietrobattista A; Morino G; De Ville De Goyet J; Bedogni G; Pinzani M
    Transl Res; 2010 Oct; 156(4):229-34. PubMed ID: 20875899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non alcoholic steatohepatitis].
    Manero E; Findor JA; Avagnina A; de Elizalde S; Elsner B
    Medicina (B Aires); 1994; 54(6):625-9. PubMed ID: 7658998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury.
    Diehl AM; Goodman Z; Ishak KG
    Gastroenterology; 1988 Oct; 95(4):1056-62. PubMed ID: 3410220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of serum ferritin and body mass index in patients with chronic hepatitis B: improved prediction of cirrhosis.
    Paul S; O'Regan K; St John A; Stuart K; Crawford D
    Hepatology; 2013 May; 57(5):2094-5. PubMed ID: 22987244
    [No Abstract]   [Full Text] [Related]  

  • 17. [Percutaneous liver biopsy in diabetics--experiences between 1968 and 1971].
    Schmidt R; Tennstedt A
    Z Arztl Fortbild (Jena); 1974 Mar; 68(6):298-302. PubMed ID: 4418773
    [No Abstract]   [Full Text] [Related]  

  • 18. Behaviour of antithrombin 3 in liver disease.
    Duckert F
    Scand J Gastroenterol Suppl; 1973; 19():109-12. PubMed ID: 4515632
    [No Abstract]   [Full Text] [Related]  

  • 19. Late nonalcoholic fatty liver disease with cirrhosis: a pathologic case of lost or mistaken identity.
    Lefkowitch JH; Morawski JL
    Semin Liver Dis; 2012 Feb; 32(1):92-8. PubMed ID: 22418891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of nonalcoholic steatohepatitis.
    Liou I; Kowdley KV
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.